SHUXING ZHANG to Drug Screening Assays, Antitumor
This is a "connection" page, showing publications SHUXING ZHANG has written about Drug Screening Assays, Antitumor.
Connection Strength
0.277
-
A novel multi-modal drug repurposing approach for identification of potent ACK1 inhibitors. Pac Symp Biocomput. 2013; 29-40.
Score: 0.095
-
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. Bioorg Med Chem. 2009 Oct 01; 17(19):6983-92.
Score: 0.075
-
Antitumor agents 252. Application of validated QSAR models to database mining: discovery of novel tylophorine derivatives as potential anticancer agents. J Comput Aided Mol Des. 2007 Jan-Mar; 21(1-3):97-112.
Score: 0.064
-
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell. 2013 Aug 01; 154(3):556-68.
Score: 0.025
-
Discovery of a novel class of AKT pleckstrin homology domain inhibitors. Mol Cancer Ther. 2008 Sep; 7(9):2621-32.
Score: 0.018